Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.54 USD | -5.22% | -13.31% | -22.21% |
24/04 | Gain Therapeutics, Inc. Announces Positive Results from the Single Ascending Dose Part of the Phase 1 Clinical Trial of GT-02287 | CI |
08/04 | Gain Therapeutics Names Gene Mack as CFO | MT |
- Stock Market
- Equities
- GANX Stock
- News Gain Therapeutics, Inc.
- MarketScreener Editorial Features